Related Experiment Video
Updated: May 13, 2026

Flow Cytometry-Based Quantification and Analysis of Myocardial B-Cells
Published on: August 17, 2022
Giant cell myocarditis associated with amoxicillin hypersensitivity reaction
Soledad Martinez1, Elvira Miranda, Patrick Kim
1Servicio Medico Legal, Av. La Paz 1012, Independencia, Santiago, Chile. soledadml@yahoo.com
A rare case of sudden unexpected death was linked to eosinophilic myocarditis, a severe heart inflammation. This condition, characterized by giant cells, may be associated with drug hypersensitivity reactions.
Area of Science:
- Cardiovascular Pathology
- Immunology
- Toxicology
Background:
- Sudden unexpected death in adults can stem from various cardiac pathologies.
- Myocarditis, inflammation of the heart muscle, presents diverse etiological factors.
- Drug hypersensitivity reactions are a known cause of systemic adverse events.
Observation:
- A case of sudden unexpected death in an adult woman was investigated.
- The autopsy revealed florid myocarditis with necrosis, fibrosis, and diffuse infiltration by eosinophils and giant cells.
- Clinical history indicated a hypersensitivity reaction to antibiotic therapy preceding death.
Findings:
- The pathological findings strongly suggest eosinophilic giant cell myocarditis.
- A temporal association between antibiotic initiation and hypersensitivity reaction was noted.
- Clinico-pathological correlation points towards drug hypersensitivity as a potential trigger.
Implications:
- This case highlights a potential link between drug hypersensitivity and the development of eosinophilic giant cell myocarditis.
- Understanding such associations is crucial for diagnosing and preventing adverse drug reactions.
- Further research into the mechanisms of drug-induced myocarditis is warranted.
Related Concept Videos
Myocarditis I: Introduction
Hypersensitivity Reactions: Immune-Complex Reactions
Drug Toxicity: Allergic Reactions
Allergic Reactions: Anaphylaxis
Hypersensitivity Reactions: Cytolytic Reactions
Myocarditis III: Medical Management